These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17205199)

  • 1. Developmental defects in trisomy 21 and mouse models.
    Delabar JM; Aflalo-Rattenbac R; Créau N
    ScientificWorldJournal; 2006 Sep; 6():1945-64. PubMed ID: 17205199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental consequences of autosomal aneuploidy in mammals.
    Gearhart JD; Oster-Granite ML; Reeves RH; Coyle JT
    Dev Genet; 1987; 8(4):249-65. PubMed ID: 2971493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
    Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome.
    Xing Z; Li Y; Cortes-Gomez E; Jiang X; Gao S; Pao A; Shan J; Song Y; Perez A; Yu T; Highsmith MR; Boadu F; Conroy JM; Singh PK; Bakin AV; Cheng J; Duan Z; Wang J; Liu S; Tycko B; Yu YE
    Hum Mol Genet; 2023 Jun; 32(13):2205-2218. PubMed ID: 37014740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Too much of a good thing: mechanisms of gene action in Down syndrome.
    Reeves RH; Baxter LL; Richtsmeier JT
    Trends Genet; 2001 Feb; 17(2):83-8. PubMed ID: 11173117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models.
    Do C; Xing Z; Yu YE; Tycko B
    Epigenomics; 2017 Feb; 9(2):189-207. PubMed ID: 27911079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The power of comparative and developmental studies for mouse models of Down syndrome.
    Moore CS; Roper RJ
    Mamm Genome; 2007 Jul; 18(6-7):431-43. PubMed ID: 17653795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the understanding of Down syndrome using mouse models.
    Yamakawa K
    Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
    Pritchard MA; Kola I
    J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mouse model for Down syndrome.
    Kazuki Y; Schulz TC; Shinohara T; Kadota M; Nishigaki R; Inoue T; Kimura M; Kai Y; Abe S; Shirayoshi Y; Oshimura M
    J Neural Transm Suppl; 2003; (67):1-20. PubMed ID: 15068235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes.
    O'Doherty A; Ruf S; Mulligan C; Hildreth V; Errington ML; Cooke S; Sesay A; Modino S; Vanes L; Hernandez D; Linehan JM; Sharpe PT; Brandner S; Bliss TV; Henderson DJ; Nizetic D; Tybulewicz VL; Fisher EM
    Science; 2005 Sep; 309(5743):2033-7. PubMed ID: 16179473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome.
    Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH
    Am J Med Genet; 2002 Feb; 107(4):317-24. PubMed ID: 11840489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aneuploidy: from a physiological mechanism of variance to Down syndrome.
    Dierssen M; Herault Y; Estivill X
    Physiol Rev; 2009 Jul; 89(3):887-920. PubMed ID: 19584316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.
    Lyle R; Gehrig C; Neergaard-Henrichsen C; Deutsch S; Antonarakis SE
    Genome Res; 2004 Jul; 14(7):1268-74. PubMed ID: 15231743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
    Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
    Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down syndrome phenotypes: the consequences of chromosomal imbalance.
    Korenberg JR; Chen XN; Schipper R; Sun Z; Gonsky R; Gerwehr S; Carpenter N; Daumer C; Dignan P; Disteche C
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4997-5001. PubMed ID: 8197171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.